
Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (FLGT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FLGT · as of Jun 9, 2026
Key Statistics
Explore Fulgent Genetics, Inc. Data
flgt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 66.7%
The FLGT analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing -18.08% downside from the current price of $18.31.
Competitors & Peers
flgt competitorsStock Performance
Full HistoryAbout Fulgent Genetics, Inc.
Fulgent Genetics, Inc. together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals glo…
what is fulgent genetics, inc. · flgt stock overview · fulgent genetics, inc. company profile · who is fulgent genetics, inc. ceo · flgt NASDAQ · fulgent genetics, inc. headquarters · fulgent genetics, inc. business segments
About Stock Overview & Key Data
Fulgent Genetics, Inc. (FLGT) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Sep 29, 2016. As of the latest trading session, FLGT stock price is $18.31, with a market capitalization of $520.0M. The stock has returned -16.05% over the past 12 months and -30.30% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Fulgent Genetics, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Fulgent Genetics, Inc. reported revenue of $322.7M and net income of -$60.5M. For detailed data — including Fulgent Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fulgent Genetics, Inc. (FLGT) stock price is $18.31. The stock is traded on NASDAQ under the ticker symbol FLGT. The 52-week range is $13.46 – $31.04.